Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. - Wikidata - awgldk - TriplyDB

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

http://www.wikidata.org/entity/Q34760593

about

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis Integrated functional, gene expression and genomic analysis for the identification of cancer targets Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.Genome profiling of ERBB2-amplified breast cancers.A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer HER2 gene amplification in breast cancer: a rogues' gallery of challenging diagnostic cases: UKNEQAS interpretation guidelines and research recommendations.Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity.Biomolecular events in cancer revealed by attractor metagenes.Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.Allelic imbalance at the HER2/TOP2A locus in breast cancer Genetic characterization of breast cancer and implications for clinical management Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression Functional characterization of the 19q12 amplicon in grade III breast cancers Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast.Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer DNA amplifications in breast cancer: genotypic-phenotypic correlations.Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis.Posterior Contraction Rates of the Phylogenetic Indian Buffet Processes.Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.Genetic analysis and preliminary function study of miR-423 in breast cancer.Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells.β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.

P2860

Q28080874-36BCE8B9-FE60-4CFB-AF34-A7B7FA85CD27 Q28245213-C58D0697-00C3-422B-83AD-0190216D3D48 Q28388257-E52F1074-6FE0-46AD-B659-073B749634ED Q28475254-C27BB4E0-BBBA-4EE1-8EB7-287ACDEF1009 Q33531529-2CD433BD-471C-4C84-B09D-577A34400F22 Q33643786-E77B15F7-16F1-47ED-91A2-534EA2BFBFE9 Q33713239-9977E4D0-2129-4089-ABB8-66386616AFAC Q33739397-B8A32406-1133-4513-A778-8842829B05A3 Q34010867-2B9AAC3A-7304-4401-8604-07D5C11141B7 Q34048024-5A31B49D-F396-41BA-91D3-B60E62AD56BC Q34202609-F17F26CB-727F-4FAD-8CEE-84AD0EA242EB Q34227531-61B6744D-9177-489F-9679-4D8117231FC5 Q34329066-0C11B43E-8588-4D29-9D29-C4A39371685E Q34437633-D40AB6FE-ABC5-4DC8-8C6A-791466D747B7 Q34611062-7C0CBFF4-F89B-4405-A1C8-2BAAD2696E8E Q35029573-3FA7F4A4-F980-43C3-A1A6-B1B8349637EE Q35496577-C895F284-CD8F-467A-8D27-02A04DDF56FD Q35573116-4B8980A1-4760-4348-804D-97E92780ACC4 Q35623047-A7C7ECE2-B353-45BD-81DE-0D51C9FA0A73 Q35663036-E796A976-EBEE-4E83-9A13-86353FD61EB6 Q35832016-870FC5D6-6534-4891-A98D-5D0DC5F9ECA4 Q35889655-9D63F777-9E1B-477F-A5DF-6DA32012BA50 Q35911314-2C94CA87-2E9C-4A35-90D6-B7DFAE27274D Q36245567-B4C79466-6F8B-4D4F-A8F1-B3E2F5F64FF8 Q36402262-1FE9E61B-69EA-4A0B-9962-BD959CB70EE0 Q37240710-508F3E8B-E2D9-4B48-BDE0-D0C59C5F8CE6 Q37247163-7D3C4ACC-8F8D-4B0B-A73E-84E3B2B8FE32 Q37284899-178D86FD-F2B9-418A-9C75-768D94AA6876 Q37345320-5D031230-C9C8-4860-B8AF-AD1284579ED5 Q37606324-2C12EAAF-7E17-4F0C-8859-49A93EE2379D Q37636623-F8B046A9-26BC-4F5C-BC57-D07782BAAE42 Q37763102-4250CA2E-AF04-4BCF-95B2-40083E08309F Q38888022-274AAFDF-91B8-445D-B3F9-E9E532CD5B9C Q39207741-540FF5E2-7651-407F-9BFC-16ECC0C24D43 Q39248311-40A5F816-3271-484E-B9C6-E79D43435EC4 Q39843781-40107A07-CAA5-403D-BC77-C89943CA4F9F Q40622697-4276C3C8-73AC-4605-980F-55DA015F8265 Q41462082-94942940-473F-419F-B523-0E48CE7A8B8C Q41846641-83F4DFEB-9D5A-4EAD-96CB-FF9ACC431B0A Q42479900-4E3B7BE0-B3C3-464B-AAD2-12FA46525A4B

P2860

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

http://www.wikidata.org/entity/Q34760593

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@ast

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@en

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@nl

type

label

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@ast

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@en

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@nl

prefLabel

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@ast

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@en

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@nl

P1433

Q34760593-F8ACC9A6-4118-4758-B389-605C6C5D4C8E

P1476

Q34760593-DD998B16-D51C-4DCF-B9FA-FC9EFE227F1A

P2093

Q34760593-18CCA636-CA11-47AD-A299-F3151C18D7DE

Q34760593-5A216F27-8891-42EA-AD7E-C2B1239E9D26

Q34760593-6259C65D-A8FA-41AB-AEE9-F607B5AE64DC

Q34760593-7E978208-590E-4F8C-9E6F-A3EF1B9D2B01

Q34760593-85C2275E-DD35-4981-BEA7-06BC009CFCC8

Q34760593-9B4979D0-E6A3-46F8-AC39-070B7B0FCC88

Q34760593-AD589918-3249-458A-9DAF-7785B854DE19

Q34760593-BE9A8139-5E9B-45D3-BB47-8BC2272C1FE0

Q34760593-DB33A26F-C464-4117-9ED3-6A3914DB788F

Q34760593-E4044F69-1A6A-489C-A544-674963817191

P2860

Q34760593-01C84D06-C51F-426F-9197-04345E3A11B5

Q34760593-10C051F7-45B8-4F62-B7A5-3B8EE0F4D423

Q34760593-20B75629-107A-4FF7-B6FA-3DE90ECBD137

Q34760593-230E7E46-6B31-48B7-B103-EA46D323A7D5

Q34760593-26E1E8FA-3A9B-4681-B1EC-15A0F733CE62

Q34760593-2D76737A-3B28-441F-B5F3-1873457FE184

Q34760593-3D8CB90C-62CB-4B8A-B468-D195FFF220F3

Q34760593-41DC7F45-5392-4DF5-8876-BDF25E71E20D

Q34760593-45F3F8FF-2E90-47D9-BBC9-B3AA65975D88

Q34760593-465D10BD-7999-415E-A786-6E2A3BD5E727

P2888

Q34760593-95995C79-727B-4907-BCA9-D64C7197BF67

P304

Q34760593-1D207A24-FC9B-444D-9077-44A65BB2FC82

P31

Q34760593-618788F8-529B-4AFF-843F-791EF233ABD5

P356

Q34760593-31ED9232-2532-4E2C-9EAB-FB8342CF9E33

P433

Q34760593-2350BBF5-3CFE-406C-8738-A65FD12C352C

P478

Q34760593-01DA87FC-C61B-4805-9367-86B44D6D8CFC

P50

Q34760593-2EF115AA-C5AC-4A23-AB37-4F87DE7EBE3A

Q34760593-4D8269D0-1B96-408C-A6E0-8E44D190FAFB

Q34760593-7A762C28-C9FD-4892-96CB-ADE7D596D748

Q34760593-ED3DDBE7-10E6-468A-8B58-DF0F78FEF60B

P577

Q34760593-70E39B48-C94D-4673-92C6-3469F4044233

P5875

Q34760593-842FE732-D6FF-43FC-B428-76B6A8533671

P6179

Q34760593-75A15F36-98B4-431B-897F-FAB22B427F64

P698

Q34760593-7E4A0391-67B3-4C83-9A9D-497104571845

P356

LABINVEST.2008.19

P1433

Laboratory Investigation

P1476

Genomic analysis of the HER2/T ...... and breast cancer cell lines.

@en

P2093

Alan Mackay

http://www.w3.org/2001/XMLSchema#string

Caterina Marchio

http://www.w3.org/2001/XMLSchema#string

Chris Jones

http://www.w3.org/2001/XMLSchema#string

David S P Tan

http://www.w3.org/2001/XMLSchema#string

Edurne Arriola

http://www.w3.org/2001/XMLSchema#string

Kerry Fenwick

http://www.w3.org/2001/XMLSchema#string

Maryou B Lambros

http://www.w3.org/2001/XMLSchema#string

Narinder Tamber

http://www.w3.org/2001/XMLSchema#string

Socorro Maria Rodriguez-Pinilla

http://www.w3.org/2001/XMLSchema#string

Suzanne C Drury

http://www.w3.org/2001/XMLSchema#string

P2860

Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer

Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Global variation in copy number in the human genome

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

A multiplex PCR predictor for aCGH success of FFPE samples.

Novel patterns of genome rearrangement and their association with survival in breast cancer.

P2888

labinvest.2008.19

P304

491-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.2008.19

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Reis-Filho

Rachael Natrajan

P577

2008-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5519106

http://www.w3.org/2001/XMLSchema#string

P6179

1047269410

http://www.w3.org/2001/XMLSchema#string

P698

18332872

http://www.w3.org/2001/XMLSchema#string